Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catalent, Inc. Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
News headline image
Executives Sell More Than $210M Of 5 Stocks ↗
Spanish stocks traded higher this morning, with the IBEX 35 Index surging to the strongest level in over two weeks. Investors, meanwhile, focused on some notable insider trades.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Catalent's Q2 Earnings Beat Street View, Lifts FY22 Guidance ↗
Catalent Inc (NYSE: CTLT) has reported Q2 FY22 sales of $1. 
Via Benzinga
News headline image
Catalent, Inc. Reports Second Quarter Fiscal 2022 Results
From Catalent, Inc.
Via Business Wire
News headline image
A Bearish Sign Appears On Catalent's Chart ↗
If history is any guide, there may be trouble ahead for shares of Catalent (NYSE:CTLT). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... 
Via Benzinga
News headline image
Expert Ratings For Catalent ↗
Analysts have provided the following ratings for Catalent (NYSE:CTLT) within the last quarter: 
Via Benzinga
News headline image
Expert Ratings For Catalent ↗
Analysts have provided the following ratings for Catalent (NYSE:CTLT) within ... 
Via Benzinga
News headline image
Where Catalent Stands With Analysts ↗
Analysts have provided the following ratings for Catalent (NYSE:CTLT) within ... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News ↗
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
News headline image
Catalent, Inc. Announces Second Quarter Fiscal Year 2022 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
News headline image
This Tattooed, Cowboy-Boot-Wearing Top CEO Refuses To Go Clean Cut ↗
John Chiminski knows he doesn't fit the traditional image of a corporate bigwig. And the Catalent CEO is not about to change. 
Via Investor's Business Daily
News headline image
FDA Concerns At Catalent Site Spurred Novo Nordisk's Wegovy Supply Woes: Report ↗
Last week, Catalent Inc (NYSE: CTLT) received an FDA write-up for its syringe filling facility in Belgium, "allegedly" the culprit behind supply shortage for... 
Via Benzinga
News headline image
Catalent Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022
From Catalent, Inc.
Via Business Wire
News headline image
Catalent, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Catalent, Inc.
Via Business Wire
News headline image
A Look Into Catalent's Price Over Earnings ↗
In the current session, Catalent Inc. (NYSE:CTLT) is trading at $128.13, after a 0.1% increase. Over the past month, the stock increased by 0.34%, and in the past... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021 ↗
Upgrades According to B of A Securities, the prior rating for Generac Holdings Inc (NYSE: 
Via Benzinga
News headline image
Catalent, Inc. to Present at the Stephens Annual Investment Conference
From Catalent, Inc.
Via Business Wire
News headline image
Catalent, inc (CTLT) Q1 2022 Earnings Call Transcript ↗
CTLT earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... 
Via Benzinga
News headline image
Catalent, Inc. Reports First Quarter Fiscal 2022 Results
From Catalent, Inc.
Via Business Wire
News headline image
Catalent, Inc. Announces First Quarter Fiscal Year 2022 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
News headline image
Chair And CEO Of Catalent Trades $22M In Company Stock ↗
John Chiminski, Chair And CEO at Catalent (NYSE:CTLT), made a large buy and sell of company shares on October 1, according to a new SEC filing. What Happened: A Form 4 filing from... 
Via Benzinga
Topics Regulatory Compliance
News headline image
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2030
From Catalent, Inc.
Via Business Wire
News headline image
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
News headline image
Catalent Announces Launch of Private Offering of $450 Million of Senior Unsecured Notes Due 2030
From Catalent, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
News headline image
Catalent, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
From Catalent, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Market Rally At Highs, Led By Apple, Growth Stocks: Weekly Review ↗
The market rally hit fresh highs this week, with growth leading the way. 
Via Investor's Business Daily
Topics Bonds Economy Stocks
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.